NASDAQ:BXRX Baudax Bio (BXRX) Stock Price, News & Analysis → FW: 234x Gain (From Weiss Ratings) (Ad) Free BXRX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$0.02▼$0.0250-Day Range$0.02▼$0.0352-Week Range$0.01▼$3.47Volume310,800 shsAverage Volume281,029 shsMarket Capitalization$1.14 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisEarningsHeadlinesInsider TradesOwnershipShort InterestSocial MediaStock AnalysisEarningsHeadlinesInsider TradesOwnershipShort InterestSocial Media Get Baudax Bio alerts: Email Address Ad Weiss RatingsThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-up before it’s too late. It’s urgent because it’s what we consider “The #1 Crypto for the AI World.”Learn more about it by watching THIS NOW. About Baudax Bio Stock (NASDAQ:BXRX)Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care related settings. The company offers ANJESO (meloxicam) injection for the management of moderate to severe pain, alone or in combination with other non-NSAID analgesics. It also develops BX1000, an intermediate-acting neuromuscular blocking agent (NMB) that is in phase II clinical trial; BX2000, an ultra- short acting NMB, which is in phase I clinical trial, as well as a proprietary blockade reversal agent; and BX3000, a NMB reversal agent that is in preclinical studies. Baudax Bio, Inc. was incorporated in 2019 and is based in Malvern, Pennsylvania.Read More Ad Weiss RatingsThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-up before it’s too late. It’s urgent because it’s what we consider “The #1 Crypto for the AI World.”Learn more about it by watching THIS NOW. BXRX Stock News HeadlinesOctober 18, 2023 | finance.yahoo.comBaudax Bio Announces Corporate UpdateOctober 2, 2023 | msn.comBaudax's (BXRX) Hemophilia A Drug Gets FDA's Orphan Drug TagMay 4, 2024 | Weiss Ratings (Ad)FW: 234x GainThis coin is an essential building block for an ongoing financial revolution of massive dimensions. As a big part of this revolution, the big banks of the world must connect to the blockchain.September 28, 2023 | investorplace.comWhy Is Baudax Bio (BXRX) Stock Up 75% Today?September 28, 2023 | marketwatch.comBaudax Bio Shares Double After Orphan Drug Designation for TI-168September 28, 2023 | markets.businessinsider.comBaudax Bio: FDA Grants Orphan Drug Designation To TI-168 For Hemophilia A With InhibitorsSeptember 18, 2023 | finance.yahoo.comHere's Why Baudax Bio, Inc. (BXRX) Is a Great 'Buy the Bottom' Stock NowSeptember 7, 2023 | finance.yahoo.comBaudax Bio to Participate in the H.C. Wainwright Global Investment ConferenceMay 4, 2024 | Weiss Ratings (Ad)FW: 234x GainThis coin is an essential building block for an ongoing financial revolution of massive dimensions. As a big part of this revolution, the big banks of the world must connect to the blockchain.August 23, 2023 | finance.yahoo.comBaudax Bio Announces Distribution of Series C Preferred Stock to Holders of its Common StockAugust 17, 2023 | finance.yahoo.comBaudax Bio Announces $1.9 Million Registered Direct Offering Priced At-The-Market under Nasdaq RulesAugust 16, 2023 | finance.yahoo.comBaudax Bio Reports Second Quarter 2023 Financial Results and Provides Business UpdateJune 30, 2023 | investorplace.comWhy Is Baudax Bio (BXRX) Stock Up 130% Today?June 8, 2023 | markets.businessinsider.comBaudax Bio (BXRX) Gets a Hold from Noble FinancialMay 22, 2023 | markets.businessinsider.comNoble Financial Sticks to Their Hold Rating for Baudax Bio (BXRX)May 15, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: MoonLake Immunotherapeutics (MLTX), Cocrystal Pharma (COCP) and Baudax Bio (BXRX)May 12, 2023 | finanznachrichten.deBaudax Bio, Inc.: Baudax Bio Reports First Quarter Financial Results and Provides Business UpdateMay 12, 2023 | baystreet.caBaudax Improves on Q1 ResultsMay 12, 2023 | msn.comRecap: Baudax Bio Q1 EarningsMay 12, 2023 | finance.yahoo.comBaudax Bio Reports First Quarter Financial Results and Provides Business UpdateMay 3, 2023 | finance.yahoo.comBaudax Bio to Present at the Sidoti Virtual Investor ConferenceMay 1, 2023 | finance.yahoo.comBaudax Bio Announces Closing of $4 Million Public OfferingApril 27, 2023 | msn.comWhy NETGEAR Shares Are Trading Lower By 18%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionApril 27, 2023 | investorplace.comWhy Is Baudax Bio (BXRX) Stock Down 52% Today?April 27, 2023 | finance.yahoo.comBaudax Bio Announces Pricing of $4 Million Public OfferingApril 25, 2023 | msn.comBaudax Bio Soars after Positive Topline DataApril 25, 2023 | msn.comBaudax Bio's Nerve Blockade Aces Mid-Stage Study In Surgery PatientsSee More Headlines Receive BXRX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Baudax Bio and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/16/2023Today5/03/2024Next Earnings (Estimated)5/10/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:BXRX CUSIPN/A CIK1780097 Webwww.baudaxbio.com Phone484-395-2440Fax484-395-2471Employees9Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($9.23) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-58,790,000.00 Net MarginsN/A Pretax Margin-18,950.64% Return on EquityN/A Return on Assets-175.11% Debt Debt-to-Equity RatioN/A Current Ratio0.07 Quick Ratio0.07 Sales & Book Value Annual Sales$1.27 million Price / Sales0.90 Cash FlowN/A Price / Cash FlowN/A Book Value($14.93) per share Price / Book0.00Miscellaneous Outstanding Shares52,460,000Free Float52,408,000Market Cap$1.14 million OptionableNot Optionable Beta1.57 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Key ExecutivesDr. Geraldine A. Henwood Ph.D. (Age 72)President, CEO & Director Comp: $633.25kMike ChoiVice President of Financial Planning & AnalysisMs. Natalie McAndrew (Age 53)Consultant & Principle Accounting Officer Dr. Chan Kim Yong Ph.D. (Age 50)Chief Scientific Officer & Director Key CompetitorsComera Life SciencesNASDAQ:CMRASciSparcNASDAQ:SPRCEvelo BiosciencesNASDAQ:EVLOGRI BioNASDAQ:GRISunshine BiopharmaNASDAQ:SBFMView All Competitors BXRX Stock Analysis - Frequently Asked Questions When is Baudax Bio's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Friday, May 10th 2024. View our BXRX earnings forecast. How were Baudax Bio's earnings last quarter? Baudax Bio, Inc. (NASDAQ:BXRX) released its quarterly earnings results on Wednesday, August, 16th. The company reported ($1.49) earnings per share for the quarter, topping the consensus estimate of ($2.04) by $0.55. When did Baudax Bio's stock split? Baudax Bio shares reverse split on the morning of Wednesday, November 30th 2022. The 1-40 reverse split was announced on Wednesday, November 30th 2022. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, November 30th 2022. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split. What other stocks do shareholders of Baudax Bio own? Based on aggregate information from My MarketBeat watchlists, some companies that other Baudax Bio investors own include Sorrento Therapeutics (SRNE), Coty (COTY), NIO (NIO), VBI Vaccines (VBIV), ADMA Biologics (ADMA), Energy Transfer (ET), Remark (MARK), Designer Brands (DBI), Geron (GERN) and Matinas BioPharma (MTNB). This page (NASDAQ:BXRX) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldFW: 234x GainWeiss RatingsStock-Picking AI Predicts #1 Stock of 2024AltimetryThe Gold Grab of the CenturyColonial Metals4 Cryptos BETTER than BitcoinTrue Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Baudax Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.